Covered recipient · General Payments record
ANDREW BLOCK
General Payments · PY2018–2024
$2,057.60
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.02 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $95.67 | 3 |
| ABBVIE INC. | $55.52 | 2 |
| MILLICENT US INC | $23.21 | 1 |
| Merck Sharp & Dohme Corporation | $21.04 | 1 |
| Sage Therapeutics, Inc. | $20.09 | 1 |
| Exeltis, USA Inc. | $15.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.49 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103337624 | CMS |
| ABBVIE INC. | $22.03 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103337626 | CMS |
| Astellas Pharma US Inc | $30.67 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426201 | CMS |
| Astellas Pharma US Inc | $33.05 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426301 | CMS |
| Astellas Pharma US Inc | $31.95 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426267 | CMS |
| Exeltis, USA Inc. | $15.49 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149987480 | CMS |
| Merck Sharp & Dohme LLC | $21.04 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141802129 | CMS |
| MILLICENT US INC | $23.21 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150904898 | CMS |
| Sage Therapeutics, Inc. | $20.09 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120393886 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.